Comparative statistics by cancer registry
Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
(Barshi, India, 1993-2000 cases followed-up until 2003)Click on cancer site (ICD-10 code) for comparison
| % | No. of excluded cases | Included cases | |||||||||
| Site | ICD-10 | Total registered | HV | DCO | DCO | No. follow-up | Others | Total | % | No. | % |
| C01-02 | Tongue | 47 | 87.2 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 47 | 100.0 |
| C03-06 | Oral cavity | 55 | 94.5 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 55 | 100.0 |
| C12-13 | Hypopharynx | 80 | 92.5 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 80 | 100.0 |
| C15 | Oesophagus | 99 | 82.8 | 1.0 | 1 | 0 | 1 | 2 | 2.0 | 97 | 98.0 |
| C16 | Stomach | 45 | 73.3 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 45 | 100.0 |
| C19-20 | Rectum | 49 | 91.8 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 49 | 100.0 |
| C22 | Liver | 48 | 83.3 | 2.1 | 1 | 0 | 0 | 1 | 2.1 | 47 | 97.9 |
| C32 | Larynx | 33 | 87.9 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 33 | 100.0 |
| C33-34 | Lung | 48 | 81.3 | 2.1 | 1 | 0 | 0 | 1 | 2.1 | 47 | 97.9 |
| C44 | Other skin | 39 | 97.4 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 39 | 100.0 |
| C50 | Breast | 124 | 91.1 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 124 | 100.0 |
| C53 | Cervix | 407 | 94.8 | 0.0 | 0 | 0 | 1 | 1 | 0.2 | 406 | 99.8 |
| C60 | Penis | 43 | 97.7 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 43 | 100.0 |
| C82-85+C96 | Non-Hodgkin lymphoma | 36 | 91.7 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 36 | 100.0 |
| C92-94 | Myeloid leukaemia | 40 | 97.5 | 0.0 | 0 | 0 | 0 | 0 | 0.0 | 40 | 100.0 |
Other tables available for this registry:
| - Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Barshi, India, 1993-2000 cases followed-up until 2003) |
| - Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Barshi, India, 1993-2000 cases followed-up until 2003) |
| - Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Barshi, India, 1993-2000 cases followed-up until 2003) |
| - Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Barshi, India, 1993-2000 cases followed-up until 2003) |
| - Table5: | Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1992 and 1993-2000 (Barshi, India) |
Registry chapter:
 | Consult the chapter in Cancer survival in developping countries (Volume II) |